Categories: Health

IPSEN – Buy-back programme – Art 5 of MAR – Week 36 – 2025

Aggregated presentation by day and by market

Statement of transactions in own shares from 1st September to 5th September 2025
             
Name of the issue Identity code of the issuer
(Legal Entity Identifier) 		Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market         (MIC Code)
  IPSEN 549300M6SGDPB4Z94P11 01/09/2025 FR0010259150    632 116,87753 AQEU  
  IPSEN 549300M6SGDPB4Z94P11 01/09/2025 FR0010259150   1 200 116,94167 CCXE  
  IPSEN 549300M6SGDPB4Z94P11 01/09/2025 FR0010259150    200 116,90 TQEX  
  IPSEN 549300M6SGDPB4Z94P11 01/09/2025 FR0010259150   2 606 117,18388 XPAR  
  IPSEN 549300M6SGDPB4Z94P11 02/09/2025 FR0010259150    300 116,20 AQEU  
  IPSEN 549300M6SGDPB4Z94P11 02/09/2025 FR0010259150    500 116,20 CCXE  
  IPSEN 549300M6SGDPB4Z94P11 02/09/2025 FR0010259150    200 116,286 TQEX  
  IPSEN 549300M6SGDPB4Z94P11 02/09/2025 FR0010259150   3 600 116,41622 XPAR  
  IPSEN 549300M6SGDPB4Z94P11 03/09/2025 FR0010259150    300 116,70 AQEU  
  IPSEN 549300M6SGDPB4Z94P11 03/09/2025 FR0010259150    600 116,68333 CCXE  
  IPSEN 549300M6SGDPB4Z94P11 03/09/2025 FR0010259150    300 116,50967 TQEX  
  IPSEN 549300M6SGDPB4Z94P11 03/09/2025 FR0010259150   3 400 116,95335 XPAR  
  IPSEN 549300M6SGDPB4Z94P11 04/09/2025 FR0010259150   1 200 120,00 CCXE  
  IPSEN 549300M6SGDPB4Z94P11 04/09/2025 FR0010259150   3 400 119,88147 XPAR  
  IPSEN 549300M6SGDPB4Z94P11 05/09/2025 FR0010259150    300 120,00 € AQEU  
  IPSEN 549300M6SGDPB4Z94P11 05/09/2025 FR0010259150    600 120,05 CCXE  
  IPSEN 549300M6SGDPB4Z94P11 05/09/2025 FR0010259150    300 120,00 TQEX  
  IPSEN 549300M6SGDPB4Z94P11 05/09/2025 FR0010259150   3 400 119,80815 XPAR  
            23 038 118,01642    
                 
GlobeNews Wire

Share
Published by
GlobeNews Wire
Tags: 2025Adventureartbuy-backFR0010259150ipsenmar”newsParis:IPNPressReleaseprogrammeRegulated_Infoweek
6 months ago

Recent Posts

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

BASEL, Switzerland, March 23, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotech focused on…

2 hours ago

Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment

March 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna…

2 hours ago

Laigo Bio completes final close of oversubscribed seed financing of 17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs

Additional funding of €4m from new co-lead investor Biovance Capital, and €1.5m from existing co-lead…

2 hours ago

Mayson Raises Pre-Seed Funding for Its Full-stack Vibe Coding Platform

The platform enables builders to turn a single prompt into production-grade software, with scalable backend…

2 hours ago

KPM Analytics Expands NexaFlo Continuous Flow Platform for Seawater Nutrient Analysis

Next-Generation Analyzer Delivers Improved Sensitivity with Proven Marine Chemistry MethodsWESTBOROUGH, Mass., March 23, 2026 /PRNewswire/…

2 hours ago

Bakery China 2026 to Kick Off in Shanghai in May, Spotlighting Global Innovations for the Baking Industry

SHANGHAI, March 23, 2026 /PRNewswire/ -- From May 20 to 23, under the theme "Innovate…

2 hours ago